Furthermore, DCIR polymorphisms are linked to patients’ susceptibility to autoimmune diseases such as rheumatoid arthritis (RA) (8), systemic lupus erythematosus (SLE) (9), and primary Sjögren’s syndrome (9). Here, CLEC4A is linked to systemic lupus erythematosus.